Clinical Experience with and Side-effects of Tacrine Hydrochloride in Alzheimer's Disease: A Pilot Study
- 1 July 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 18 (4) , 223-229
- https://doi.org/10.1093/ageing/18.4.223
Abstract
Pharmacological manipulation of central cholinergic neurotransmisson may prove beneficial in the treatment of Alzheimer's disease (AD) Tacrine hydrochloride is a central anticholinesterase which has been said to improve intellectual function in patients with AD. We report here our clinical experience with this drug in eight patients with AD, diagnosed according to DSM III and NINCDS-ADRDA criteria. Cholinergic side-effects occurred in five patients, three of whom tolerated a reduced dose. Liver function tests rose within the normal range in all patients and became abnormal in one.Keywords
This publication has 4 references indexed in Scilit:
- Diagnosing dementia: do we get it right?BMJ, 1988
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Validity of clinical diagnosis in dementia: a prospective clinicopathological study.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- THE EVALUATION OF DRUGS IN ALZHEIMER'S DISEASEAge and Ageing, 1979